Determining the Optimal Dosage Regimen for H2-Receptor Antagonist Therapy—A Dose Validation Approach
Karl E. Peace
Part of the Public Health Commons
Works by Brian Dickson in Public Health
1989
1988
Cost Benefit Assessment of Misoprostol to Cimetidine in the Treatment of Peptic Ulcer Disease
Karl E. Peace
A Blinded Endoscopic Comparative Study of Misoprostol vs. Sucralfate and Placebo in the Prevention of Aspirin Induced Gastric and Duodenal Ulceration
Karl E. Peace
Comparison of Equal-Weight Oral Dosages of Verapamil Hydrochloride and Diltiazem Hydrochloride in Patients with Mild to Moderate Hypertension
Karl E. Peace
1987
The Effect of Acute Treatment with Misoprostol (MIS), Cimetidine (CIM) and Placebo on Spontaneous Duodenal Ulcer Relapse
Karl E. Peace
Determining the Optimal Dosage Regimen for H2-receptor Antagonist Therapy – a dose validation approach
Karl E. Peace
1986
Bioequivalence of a new 800 mg Cimetidine Tablet with Commercially Available 400 mg Tablets
Karl E. Peace